109 related articles for article (PubMed ID: 12755548)
21. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
[TBL] [Abstract][Full Text] [Related]
22. Intra-individual comparison of different gadolinium-based contrast agents in the quantitative evaluation of C6 glioma with dynamic contrast-enhanced magnetic resonance imaging.
Li Y; Liu G; Lou X; Chen Z; Ma L
Sci China Life Sci; 2017 Jan; 60(1):11-15. PubMed ID: 28078511
[TBL] [Abstract][Full Text] [Related]
23. Quantification of the effect of water exchange in dynamic contrast MRI perfusion measurements in the brain and heart.
Larsson HB; Rosenbaum S; Fritz-Hansen T
Magn Reson Med; 2001 Aug; 46(2):272-81. PubMed ID: 11477630
[TBL] [Abstract][Full Text] [Related]
24. Excretion of proteins by rat kidney during various types of diuresis.
Kutina AV; Zakharov VV; Natochin YV
Bull Exp Biol Med; 2008 Dec; 146(6):671-4. PubMed ID: 19513351
[TBL] [Abstract][Full Text] [Related]
25. Effect of varying the molecular weight of the MR contrast agent Gd-DTPA-polylysine on blood pharmacokinetics and enhancement patterns.
Vexler VS; Clément O; Schmitt-Willich H; Brasch RC
J Magn Reson Imaging; 1994; 4(3):381-8. PubMed ID: 8061437
[TBL] [Abstract][Full Text] [Related]
26. Effects of a new diuretic (piretanide) compared with furosemide on renal diluting and concentrating mechanisms in patients with the nephrotic syndrome.
Marone C; Reubi FC
Eur J Clin Pharmacol; 1980; 17(3):165-71. PubMed ID: 7363930
[TBL] [Abstract][Full Text] [Related]
27. Sodium magnetic resonance imaging of diuresis: spatial and kinetic response.
Maril N; Margalit R; Mispelter J; Degani H
Magn Reson Med; 2005 Mar; 53(3):545-52. PubMed ID: 15723399
[TBL] [Abstract][Full Text] [Related]
28. Enhancement effects and relaxivities of gadolinium-DTPA at 1.5 versus 3 Tesla: a phantom study.
Sasaki M; Shibata E; Kanbara Y; Ehara S
Magn Reson Med Sci; 2005; 4(3):145-9. PubMed ID: 16462135
[TBL] [Abstract][Full Text] [Related]
29. Quantification of dynamic contrast-enhanced MR imaging of the knee in children with juvenile rheumatoid arthritis based on pharmacokinetic modeling.
Workie DW; Dardzinski BJ; Graham TB; Laor T; Bommer WA; O'Brien KJ
Magn Reson Imaging; 2004 Nov; 22(9):1201-10. PubMed ID: 15607091
[TBL] [Abstract][Full Text] [Related]
30. Gadolinium-DTPA enhanced dynamic MR imaging in the evaluation of cisplatinum nephrotoxicity.
Frank JA; Choyke PL; Girton ME; Austin HA; Sievenpiper C; Inscoe SW; Black JL; Carvlin MJ; Dwyer AJ
J Comput Assist Tomogr; 1989; 13(3):448-59. PubMed ID: 2723175
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent.
Wang X; Feng Y; Ke T; Schabel M; Lu ZR
Pharm Res; 2005 Apr; 22(4):596-602. PubMed ID: 15846467
[TBL] [Abstract][Full Text] [Related]
32. Subtracted synthetic images in Gd-DTPA enhanced MR.
Suto Y; Caner BE; Tamagawa Y; Matsuda T; Kimura I; Kimura H; Toyama T; Ishii Y
J Comput Assist Tomogr; 1989; 13(5):925-8. PubMed ID: 2778158
[TBL] [Abstract][Full Text] [Related]
33. A Manganese-based Alternative to Gadolinium: Contrast-enhanced MR Angiography, Excretion, Pharmacokinetics, and Metabolism.
Gale EM; Wey HY; Ramsay I; Yen YF; Sosnovik DE; Caravan P
Radiology; 2018 Mar; 286(3):865-872. PubMed ID: 29117483
[TBL] [Abstract][Full Text] [Related]
34. Transcytolemmal water exchange in pharmacokinetic analysis of dynamic contrast-enhanced MRI data in squamous cell carcinoma of the head and neck.
Kim S; Quon H; Loevner LA; Rosen MA; Dougherty L; Kilger AM; Glickson JD; Poptani H
J Magn Reson Imaging; 2007 Dec; 26(6):1607-17. PubMed ID: 17968962
[TBL] [Abstract][Full Text] [Related]
35. Forced diuresis with the RenalGuard system: impact on contrast induced acute kidney injury.
Solomon R
J Cardiol; 2014 Jan; 63(1):9-13. PubMed ID: 24239195
[TBL] [Abstract][Full Text] [Related]
36. [A pharmacokinetic analysis of Gd-DTPA enhancement in MRT in breast carcinoma].
Hess T; Knopp MV; Hoffmann U; Brix G; Junkermann H; Zuna I; von Fournier D; van Kaick G
Rofo; 1994 Jun; 160(6):518-23. PubMed ID: 8011997
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis.
Ni Y; Petré C; Miao Y; Yu J; Cresens E; Adriaens P; Bosmans H; Semmler W; Baert AL; Marchal G
Invest Radiol; 1997 Dec; 32(12):770-9. PubMed ID: 9406018
[TBL] [Abstract][Full Text] [Related]
38. Gadolinium-chitosan nanoparticles as a novel contrast agent for potential use in clinical bowel-targeted MRI: a feasibility study in healthy rats.
Cheng JJ; Zhu J; Liu XS; He DN; Xu JR; Wu LM; Zhou J; Feng Q
Acta Radiol; 2012 Oct; 53(8):900-7. PubMed ID: 22919051
[TBL] [Abstract][Full Text] [Related]
39. Basic physics of MR contrast agents and maximization of image contrast.
Hendrick RE; Haacke EM
J Magn Reson Imaging; 1993; 3(1):137-48. PubMed ID: 8428081
[TBL] [Abstract][Full Text] [Related]
40. Functional evaluation of transplanted kidneys by Gd-DTPA enhanced turbo FLASH MR imaging.
Nakashima R; Yamashita Y; Tomiguchi S; Tsuji A; Takahashi M
Radiat Med; 1996; 14(5):251-6. PubMed ID: 8988504
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
